Found: 6
Select item for more details and to access through your institution.
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study).
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1527, doi. 10.1111/dom.14061
- By:
- Publication type:
- Article
Effects of N-acetylcysteine, Quercetin and Apocynin on Diabetic Nephropathy in OLETF rats.
- Published in:
- Diabetes, 2007, v. 56, p. A604
- By:
- Publication type:
- Article
Short Insulin Tolerance Test May Determine Thiazolidinediones Treatment in Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A578
- By:
- Publication type:
- Article
Prevalence of Metabolic Syndrome According to the Progression of Menopause in Korean Women: Relationship Between the Menstrual Stage and Metabolic Syndrome Components.
- Published in:
- Diabetes, 2007, v. 56, p. A255
- By:
- Publication type:
- Article
1140-P: Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes: A Multicenter, Active-Controlled, Randomized Study with Open Label Extension (EVERGREEN Study).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1140-P
- By:
- Publication type:
- Article
2033-P: APX-115, a Pan-NADPH Oxidase (NOX) Inhibitor, Ameliorates Diabetic Nephropathy in NOX5 Transgenic Mice.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2033-P
- By:
- Publication type:
- Article